Opto Circuits (India) is currently trading at Rs. 207.70, up by 4.85 points or 2.39% from its previous closing of Rs. 202.85 on the BSE.
The scrip opened at Rs. 201.00 and has touched a high and low of Rs. 209.25 and Rs. 201.00 respectively. So far 71,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 310.40 on 09-May-2011 and a 52 week low of Rs. 187.00 on 07-Oct-2011.
Last one week high and low of the scrip stood at Rs. 210.00 and Rs. 189.00 respectively. The current market cap of the company is Rs. 3,871.00 crore.
The promoters holding in the company stood at 28.05% while Institutions and Non-Institutions held 39.46% and 32.49% respectively.
Opto Circuits’ (India) subsidiary and a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices - Cardiac Science Corporation, has been selected to supply hundreds of Powerheart G3 AEDs towards the campaign ‘Defib Your Club, For Life’, to reduce deaths from sudden cardiac arrest (SCA) among athletes, officials and spectators in sporting clubs of Victoria, Australia. 500 clubs in Victoria will be equipped with Cardiac Science Powerheart AEDs.
Through its partnership with Cardiac Science, the campaign provides a comprehensive defibrillation program, including training, that is specifically tailored to the needs of sporting clubs. The program has won accolades from heart safety experts, who believe it will eventually go nationwide.
Opto Circuits India is a multinational medical device company headquartered out of Bengaluru, India. The company designs, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments in more than 150 countries.
| Company Name | CMP |
|---|---|
| Lenskart Solutions | 489.50 |
| Poly Medicure | 1651.20 |
| Laxmi Denta | 214.95 |
| Nureca Ltd. | 289.30 |
| Hemant Surgical Inds | 301.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: